GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BCAL Diagnostics Ltd (ASX:BDX) » Definitions » Accumulated other comprehensive income (loss)

BCAL Diagnostics (ASX:BDX) Accumulated other comprehensive income (loss) : A$0.29 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is BCAL Diagnostics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. BCAL Diagnostics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was A$0.29 Mil.

BCAL Diagnostics's quarterly Accumulated other comprehensive income (loss) increased from Dec. 2022 (A$0.32 Mil) to Jun. 2023 (A$0.55 Mil) but then declined from Jun. 2023 (A$0.55 Mil) to Dec. 2023 (A$0.29 Mil).

BCAL Diagnostics's annual Accumulated other comprehensive income (loss) increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.32 Mil) and increased from Jun. 2022 (A$0.32 Mil) to Jun. 2023 (A$0.55 Mil).


BCAL Diagnostics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for BCAL Diagnostics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BCAL Diagnostics Accumulated other comprehensive income (loss) Chart

BCAL Diagnostics Annual Data
Trend Jun22 Jun23
Accumulated other comprehensive income (loss)
0.32 0.55

BCAL Diagnostics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial 0.32 0.32 0.32 0.55 0.29

BCAL Diagnostics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


BCAL Diagnostics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of BCAL Diagnostics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


BCAL Diagnostics (ASX:BDX) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Queen Victoria Building, GPO Box Q128, Sydney, NSW, AUS, 1230
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.